SEC Form 4 · accession 0001078782-18-000074
VOLITIONRX LTD · VNRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacob Vincent Micallef
Officer — Chief Scientific Officer
Period of report
Jan 23, 2018
Accepted (ET)
Jan 25, 2018 · 5:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000093314
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.00 | Jan 23, 2018 | A | 75,000 | A | Jan 23, 2019 | Jan 23, 2024 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1A total of 75,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.